Ingersoll Rand to acquire ILC Dover for ~$2.325B in cash; life sciences platform creation

Ingersoll Rand Inc.

Upfront purchase price of ~$2.325 billion; earnout based on 2024 efficiency metrics adds less than one turn to ~17x upfront EBITDA multiple.
ILC Dover has ~$400M 2024E revenue, mid-30s Adjusted EBITDA margins, ~75% revenue from consumable/recurring streams.
Acquisition expected to close Q2 2024 subject to regulatory approvals; expands addressable market by >$10B to ~$65B.
Corey Walker, ILC President and CEO, to lead new life sciences platform within P&ST segment, reporting to Ingersoll Rand CEO.
Deal immediately accretive to growth and margin rates; ROIC expected in high single digits by year three.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.